In the same year, Yu’s laboratory transduced human NK-92 cell line with a lentiviral construct that harbored a CAR targeting epidermal growth factor receptor (EGFR), which showed to be effective in the inhibition of glioblastoma growth and prolonged tumor-bearing mice survival (50). Here, EGFR is linked to neoplasm.